Latest Advances in Lung Cancer Research

Penn Medicine receives $9 million for tumor-illuminating technology to improve lung cancer surgery outcomes.

Memorial Sloan Kettering researchers find a new SCLC subtype with normal Rb protein, potentially treatable with existing CDK4/6 inhibitor drugs.

Study shows nearly half of high-risk lung cancer screenings have delayed follow-up, with current smokers at higher risk of delays in care.

Study finds White Americans 50% more likely to receive lung cancer screenings than Black Americans; health perception influences screening likelihood.

Lung cancer screening disparities persist for Black Americans, with USPSTF guidelines and risk models failing to adequately address racial differences in risk and diagnosis.

Moffitt Cancer Center seeks federal funding for a mobile unit to improve lung cancer screening rates, especially for marginalized communities, aiming for operational status by early 2024.

Medicare expands LDCT lung cancer screening eligibility, lowering age to 50 and pack-year history to 20, streamlining processes to improve early detection.

Mount Sinai study shows earlier lung cancer diagnosis via CT screening significantly reduces deaths, underscoring the need for widespread screening adherence.

Artificial intelligence blood test to detect lung cancer. Researchers developed novel technology to detect lung cancer in patients.

Address disparities in lung cancer screening. Abstracts presented at ASCO’s 2021 annual meeting address disparities in lung cancer screening.

Lower risk of brain mets from screening. LDCT Screening linked to lower risk of brain mets for lung cancer patients.

Latest in depth analysis and recommendations for lung cancer screening from the United States Preventive Services Task Force